These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23871992)

  • 41. New approaches towards the understanding of integral membrane proteins: A structural perspective on G protein-coupled receptors.
    Grisshammer R
    Protein Sci; 2017 Aug; 26(8):1493-1504. PubMed ID: 28547763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of an antibody fragment that stabilizes GPCR/G-protein complexes.
    Maeda S; Koehl A; Matile H; Hu H; Hilger D; Schertler GFX; Manglik A; Skiniotis G; Dawson RJP; Kobilka BK
    Nat Commun; 2018 Sep; 9(1):3712. PubMed ID: 30213947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors.
    Jacobson KA; Costanzi S
    Mol Pharmacol; 2012 Sep; 82(3):361-71. PubMed ID: 22695719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
    Rosenbaum DM; Cherezov V; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Yao XJ; Weis WI; Stevens RC; Kobilka BK
    Science; 2007 Nov; 318(5854):1266-73. PubMed ID: 17962519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR).
    Floquet N; M'Kadmi C; Perahia D; Gagne D; Bergé G; Marie J; Banères JL; Galleyrand JC; Fehrentz JA; Martinez J
    J Mol Biol; 2010 Jan; 395(4):769-84. PubMed ID: 19782690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current assessment of docking into GPCR crystal structures and homology models: successes, challenges, and guidelines.
    Beuming T; Sherman W
    J Chem Inf Model; 2012 Dec; 52(12):3263-77. PubMed ID: 23121495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conformational restriction of G-proteins Coupled Receptors (GPCRs) upon complexation to G-proteins: a putative activation mode of GPCRs?
    Louet M; Karakas E; Perret A; Perahia D; Martinez J; Floquet N
    FEBS Lett; 2013 Aug; 587(16):2656-61. PubMed ID: 23851072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of 16 human G protein-coupled receptors expressed in baculovirus-infected insect cells.
    Akermoun M; Koglin M; Zvalova-Iooss D; Folschweiller N; Dowell SJ; Gearing KL
    Protein Expr Purif; 2005 Nov; 44(1):65-74. PubMed ID: 15951199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transmembrane signaling by GPCRs: insight from rhodopsin and opsin structures.
    Choe HW; Park JH; Kim YJ; Ernst OP
    Neuropharmacology; 2011 Jan; 60(1):52-7. PubMed ID: 20708633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emerging structural insights into biased GPCR signaling.
    Shukla AK; Singh G; Ghosh E
    Trends Biochem Sci; 2014 Dec; 39(12):594-602. PubMed ID: 25458114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. X-ray structural information of GPCRs in drug design: what are the limitations and where do we go?
    Topiol S
    Expert Opin Drug Discov; 2013 Jun; 8(6):607-20. PubMed ID: 23537065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recognition of GPCRs by peptide ligands and membrane compartments theory: structural studies of endogenous peptide hormones in membrane environment.
    Sankararamakrishnan R
    Biosci Rep; 2006 Apr; 26(2):131-58. PubMed ID: 16773462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A G protein-coupled receptor at work: the rhodopsin model.
    Hofmann KP; Scheerer P; Hildebrand PW; Choe HW; Park JH; Heck M; Ernst OP
    Trends Biochem Sci; 2009 Nov; 34(11):540-52. PubMed ID: 19836958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs.
    De Groof TWM; Bobkov V; Heukers R; Smit MJ
    Mol Cell Endocrinol; 2019 Mar; 484():15-24. PubMed ID: 30690070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Function-related dynamics of GPCRs.
    Ueda T; Imai S; Shimada I
    J Magn Reson; 2022 Mar; 336():107164. PubMed ID: 35168190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure modeling of all identified G protein-coupled receptors in the human genome.
    Zhang Y; Devries ME; Skolnick J
    PLoS Comput Biol; 2006 Feb; 2(2):e13. PubMed ID: 16485037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Applications of molecular replacement to G protein-coupled receptors.
    Kruse AC; Manglik A; Kobilka BK; Weis WI
    Acta Crystallogr D Biol Crystallogr; 2013 Nov; 69(Pt 11):2287-92. PubMed ID: 24189241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of GPCR structures on pharmacology and structure-based drug design.
    Congreve M; Marshall F
    Br J Pharmacol; 2010 Mar; 159(5):986-96. PubMed ID: 19912230
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structures of class B G protein-coupled receptors: prospects for drug discovery.
    Hausch F
    Angew Chem Int Ed Engl; 2013 Dec; 52(49):12783-5. PubMed ID: 24127232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular modeling of vasopressin receptor and in silico screening of V1b receptor antagonists.
    Hagiwara Y; Ohno K; Kamohara M; Takasaki J; Watanabe T; Fukunishi Y; Nakamura H; Orita M
    Expert Opin Drug Discov; 2013 Aug; 8(8):951-64. PubMed ID: 23682717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.